TY - JOUR
T1 - Control of parallelized bioreactors II
T2 - probabilistic quantification of carboxylic acid reductase activity for bioprocess optimization
AU - von den Eichen, Nikolas
AU - Osthege, Michael
AU - Dölle, Michaela
AU - Bromig, Lukas
AU - Wiechert, Wolfgang
AU - Oldiges, Marco
AU - Weuster-Botz, Dirk
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Autonomously operated parallelized mL-scale bioreactors are considered the key to reduce bioprocess development cost and time. However, their application is often limited to products with very simple analytics. In this study, we investigated enhanced protein expression conditions of a carboxyl reductase from Nocardia otitidiscaviarum in E. coli. Cells were produced with exponential feeding in a L-scale bioreactor. After the desired cell density for protein expression was reached, the cells were automatically transferred to 48 mL-scale bioreactors operated by a liquid handling station where protein expression studies were conducted. During protein expression, the feed rate and the inducer concentration was varied. At the end of the protein expression phase, the enzymatic activity was estimated by performing automated whole-cell biotransformations in a deep-well-plate. The results were analyzed with hierarchical Bayesian modelling methods to account for the biomass growth during the biotransformation, biomass interference on the subsequent product assay, and to predict absolute and specific enzyme activities at optimal expression conditions. Lower feed rates seemed to be beneficial for high specific and absolute activities. At the optimal investigated expression conditions an activity of 1153UmL-1 was estimated with a 90 % credible interval of [992,1321]UmL-1. This is about 40-fold higher than the highest published data for the enzyme under investigation. With the proposed setup, 192 protein expression conditions were studied during four experimental runs with minimal manual workload, showing the reliability and potential of automated and digitalized bioreactor systems.
AB - Autonomously operated parallelized mL-scale bioreactors are considered the key to reduce bioprocess development cost and time. However, their application is often limited to products with very simple analytics. In this study, we investigated enhanced protein expression conditions of a carboxyl reductase from Nocardia otitidiscaviarum in E. coli. Cells were produced with exponential feeding in a L-scale bioreactor. After the desired cell density for protein expression was reached, the cells were automatically transferred to 48 mL-scale bioreactors operated by a liquid handling station where protein expression studies were conducted. During protein expression, the feed rate and the inducer concentration was varied. At the end of the protein expression phase, the enzymatic activity was estimated by performing automated whole-cell biotransformations in a deep-well-plate. The results were analyzed with hierarchical Bayesian modelling methods to account for the biomass growth during the biotransformation, biomass interference on the subsequent product assay, and to predict absolute and specific enzyme activities at optimal expression conditions. Lower feed rates seemed to be beneficial for high specific and absolute activities. At the optimal investigated expression conditions an activity of 1153UmL-1 was estimated with a 90 % credible interval of [992,1321]UmL-1. This is about 40-fold higher than the highest published data for the enzyme under investigation. With the proposed setup, 192 protein expression conditions were studied during four experimental runs with minimal manual workload, showing the reliability and potential of automated and digitalized bioreactor systems.
KW - Automation
KW - Bayesian modelling
KW - Bioprocess development
KW - Escherichia coli
KW - Protein expression
KW - Stirred-tank bioreactors
KW - Whole-cell catalysis
UR - http://www.scopus.com/inward/record.url?scp=85141091959&partnerID=8YFLogxK
U2 - 10.1007/s00449-022-02797-7
DO - 10.1007/s00449-022-02797-7
M3 - Article
C2 - 36307614
AN - SCOPUS:85141091959
SN - 1615-7591
VL - 45
SP - 1939
EP - 1954
JO - Bioprocess and Biosystems Engineering
JF - Bioprocess and Biosystems Engineering
IS - 12
ER -